Critical Role of Automation in the Manufacture of Cell & Gene Therapies
Guest Editor - Dr Qasim Rafiq, University College London, UKAdvancing the discussions around this critical topic, the 3rd Annual Automation spotlight focuses on the latest developments including:
- Critical analysis of the different approaches to automation - balancing the need for flexibility with quality control and cost-effective scaleability with an indpeth look at the pros and cons of end-to-end automated manufacturing solutions vs integrated platforms.
- The latest advances in automation across various cell therapy manufacturing platforms and bioprocesses including cell culture and expansion, analytical and characterization tools, process monitoring and control.
- The key considerations when deciding to automate a complex biomanufacturing process such as autologous cell therapy manufacture, with in-depth discussion of the impact on cost of goods and risk management.
Moving from Retrofitting to Made for Purpose Manufacturing Equipment
Real-world insights into automated solutions for cell & gene therapy bioprocessing
What are your cell selection pain points?
Latest Advances in Automated Platforms for Autologous Cell & Gene Therapy Manufacturing
Critical Role of Automation in the Manufacture of Cell & Gene Therapies: Full Spotlight
Automation: what will the cell therapy laboratory of the future look like?
Augmenting Automated Analytics Using Fluorescent Nanosensors
Automated Cell Expansion: Trends & Outlook of Critical Technologies
Emerging Automated Approaches for Cell and Gene Therapy Manufacture
Strategies for Dealing with Donor Variability
Automation: the Key Enabler of Point-of-Care Cell & Gene Therapy Manufacturing
Industry Perspectives on Industrialization & Automation in Cell & Gene Therapy Supply Chains